NexgenRx, Inc. (NXG.V)
0.33
-0.02
(-5.71%)
CAD |
TSXV |
Feb 11, 16:00
NexgenRx Total Assets (Quarterly) : 39.20M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cronos Group, Inc. | 1.640B |
| Cannara Biotech, Inc. | 173.84M |
| Medexus Pharmaceuticals, Inc. | 207.93M |
| Arch Biopartners, Inc. | 0.1045M |
| Biocure Technology, Inc. | 2.018M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.91M |
| Shareholders Equity (Quarterly) | 8.289M |
| Debt to Equity Ratio | 0.0501 |
| Current Ratio | 1.108 |
| Net Debt Paydown Yield | 0.05% |